Antineutrophil cytoplasmic antibody (ANCA) associated lung-renal vasculitides: A single centre perspective Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012
The oxidation induced by antimyeloperoxidase antibodies triggers fibrosis in microscopic polyangiitis Source: Eur Respir J 2011; 37: 1503-1513 Year: 2011
Antineutrophil cytoplasmic antibodies (ANCA) and antinuclear antibodies (ANA) in cystic fibrosis (CF) Source: Eur Respir J 2004; 24: Suppl. 48, 385s Year: 2004
Detection of antineutrophil cytoplasmic antibodies (ANCA) and antinuclear antibodies (ANA) in children and adults with cystic fibrosis (CF) Source: Eur Respir J 2007; 30: Suppl. 51, 648s Year: 2007
ANCA (antineutrophil cytoplasmic autoantibody) in the chronic lower respiratory tract infection Source: Eur Respir J 2002; 20: Suppl. 38, 444s Year: 2002
Antineutrophil cytoplasmic antibodies (ANCA) associated-bronchiectasis appears more severe than "idiopathic" bronchiectasis Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice Year: 2015
Cure bronchiectasis associated with anti-neutrophil cytoplasmatic antibodies (ANCA) with immunosuppressive therapy Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015
Prevalence and clinical significance of auto-antibodies in adults with cystic fibrosis Source: Eur Respir J 2009; 34: 1079-1085 Year: 2009
Frequency of autoantibodies (autoAb) and circulating immune complexes (CI) occurrences in pulmonary sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 313s Year: 2002
Myositis-specific antibodies identify a distinct interstitial pneumonia with autoimmune features phenotype Source: Eur Respir J, 56 (6) 2001205; 10.1183/13993003.01205-2020 Year: 2020
Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma Source: Eur Respir J 2012; 39: 1405-1414 Year: 2012
Antinucleosome autoantibody in a patient with sarcoidosis and antiphospholipid antibodies Source: Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases Year: 2010
Anti-proteinase 3 antibodies prime CD14-dependent leukocyte activation Source: Eur Respir J 2002; 20: Suppl. 38, 228s Year: 2002
Anti-endothelial cell antibodies in patients with idiopathic nonspecific interstitial pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 308s Year: 2006
Pulmonary involvement in polymyositis with anti-signal recognition particle autoantibody Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease Year: 2009
Determining early response to anti-IL5/IL5R monoclonal antibodies in severe eosinophilic asthma Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020
High prevalence of serum IgA antibodies against gliadin in patients with interstitial lung diseases confirmed by immunoblotting Source: Eur Respir J 2003; 22: Suppl. 45, 227s Year: 2003
Specific antibody response to polysaccharide antigens in cystic fibrosis adult patients Source: Eur Respir J 2002; 20: Suppl. 38, 158s Year: 2002
Clinical and pathological findings of patients with interstitial lung diseases associated with antisynthetase other than Jo-1 antibodies Source: Eur Respir J 2005; 26: Suppl. 49, 541s Year: 2005
Serum anti DFS70 antibody titer and lung functional impairment in patients with interstitial lung disease (ILD) Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017